These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 34805014)

  • 1. Albumin-Bilirubin (ALBI) and Monocyte to Lymphocyte Ratio (MLR)-Based Nomogram Model to Predict Tumor Recurrence of AFP-Negative Hepatocellular Carcinoma.
    Mao S; Yu X; Shan Y; Fan R; Wu S; Lu C
    J Hepatocell Carcinoma; 2021; 8():1355-1365. PubMed ID: 34805014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomogram Based on Platelet-Albumin-Bilirubin for Predicting Tumor Recurrence After Surgery in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients.
    Yang C; Wu X; Liu J; Wang H; Jiang Y; Wei Z; Cai Q
    J Hepatocell Carcinoma; 2023; 10():43-55. PubMed ID: 36660412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preoperative nomogram for microvascular invasion prediction based on clinical database in hepatocellular carcinoma.
    Mao S; Yu X; Yang Y; Shan Y; Mugaanyi J; Wu S; Lu C
    Sci Rep; 2021 Jul; 11(1):13999. PubMed ID: 34234239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of nomogram models of inflammatory markers based on clinical database to predict prognosis for hepatocellular carcinoma after surgical resection.
    Mao S; Yu X; Sun J; Yang Y; Shan Y; Sun J; Mugaanyi J; Fan R; Wu S; Lu C
    BMC Cancer; 2022 Mar; 22(1):249. PubMed ID: 35255845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence of Hepatocellular Carcinoma in Patients with Low Albumin-Bilirubin Grade in TACE Combined with Ablation: A Random Forest Cox Predictive Model.
    Xiong Y; Qiao W; Mei T; Li K; Jin R; Zhang Y
    J Hepatocell Carcinoma; 2024; 11():1375-1388. PubMed ID: 39005969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre- to postoperative alpha-fetoprotein ratio-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma.
    Yang C; Wang H; Liu J; Yang F; Lv L; Jiang Y; Cai Q
    Front Oncol; 2023; 13():1134933. PubMed ID: 37124520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New nomogram predicts the recurrence of hepatocellular carcinoma in patients with negative preoperative serum AFP subjected to curative resection.
    Gan W; Huang JL; Zhang MX; Fu YP; Yi Y; Jing CY; Fan J; Zhou J; Qiu SJ
    J Surg Oncol; 2018 Jun; 117(7):1540-1547. PubMed ID: 29572833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Preoperative ALBI and FIB-4 Is Associated with Recurrence of Hepatocellular Carcinoma After Curative Hepatectomy.
    Liao R; Li DW; Du CY; Li M
    J Gastrointest Surg; 2018 Oct; 22(10):1679-1687. PubMed ID: 29777455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A New Prognostic Algorithm Predicting HCC Recurrence in Patients With Barcelona Clinic Liver Cancer Stage B Who Received PA-TACE.
    Hu S; Gan W; Qiao L; Ye C; Wu D; Liao B; Yang X; Jiang X
    Front Oncol; 2021; 11():742630. PubMed ID: 34745962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of survival and analysis of prognostic factors for patients with AFP negative hepatocellular carcinoma: a population-based study.
    Liu C; Li Z; Zhang Z; Li J; Xu C; Jia Y; Zhang C; Yang W; Wang W; Wang X; Liang K; Peng L; Wang J
    BMC Gastroenterol; 2024 Mar; 24(1):93. PubMed ID: 38438972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and Validation of a Novel Nomogram Predicting Recurrence in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Post-Surgery Using an Innovative Liver Function-Nutrition-Inflammation-Immune (LFNII) Score: A Bicentric Investigation.
    Zhang BL; Liu J; Diao G; Chang J; Xue J; Huang Z; Zhao H; Yu L; Cai J
    J Hepatocell Carcinoma; 2024; 11():489-508. PubMed ID: 38463544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative albumin-bilirubin grade combined with aspartate aminotransferase-to-platelet count ratio index predict outcomes of patients with hepatocellular carcinoma within Milan criteria after liver resection.
    Luo H; Li C; Chen L
    Biosci Trends; 2019 May; 13(2):176-181. PubMed ID: 31061272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of a predictive model for acute liver failure after hepatectomy based on neutrophil-to-lymphocyte ratio and albumin-bilirubin score.
    Li XP; Bao ZT; Wang L; Zhang CY; Yang W
    World J Gastrointest Surg; 2024 Apr; 16(4):1087-1096. PubMed ID: 38690037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OHCCPredictor: an online risk stratification model for predicting survival duration of older patients with hepatocellular carcinoma.
    Tan J; Yu Y; Lin X; He Y; Jin W; Qian H; Li Y; Xu X; Zhao Y; Ning J; Zhang Z; Chen J; Wu X
    Hepatol Int; 2024 Apr; 18(2):550-567. PubMed ID: 37067674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel inflammation-based prognostic nomograms for individualized prediction in hepatocellular carcinoma after radical resection.
    Zeng J; Zeng J; Wu Q; Lin K; Zeng J; Guo P; Zhou W; Liu J
    Ann Transl Med; 2020 Sep; 8(17):1061. PubMed ID: 33145280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Establishing and Externally Validating a Hemoglobin, Albumin, Lymphocyte, and Platelet (HALP) Score-Based Nomogram for Predicting Early Recurrence in BCLC Stage 0/A Hepatocellular Carcinoma Patients After Radical Liver Resection: A Multi-Center Study.
    Liu X; Qiu Z; Ndhlovu E; Wan Y; Sun H; Wang S; Cao Y; Zhu P
    J Hepatocell Carcinoma; 2024; 11():1127-1141. PubMed ID: 38895590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Albumin-bilirubin (ALBI) grade-based nomogram to predict tumor recurrence in patients with hepatocellular carcinoma.
    Ho SY; Hsu CY; Liu PH; Hsia CY; Su CW; Huang YH; Hou MC; Huo TI
    Eur J Surg Oncol; 2019 May; 45(5):776-781. PubMed ID: 30401507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a nomogram to predict liver metastasis for pancreatic ductal adenocarcinoma after radical resection.
    Tong J; Jiang W; Mao S; Wu S; Lu C
    Front Oncol; 2022; 12():1040411. PubMed ID: 36479089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new prognostic model predicting hepatocellular carcinoma early recurrence in patients with microvascular invasion who received postoperative adjuvant transcatheter arterial chemoembolization.
    Mao S; Shan Y; Yu X; Huang J; Fang J; Wang M; Fan R; Wu S; Lu C
    Eur J Surg Oncol; 2023 Jan; 49(1):129-136. PubMed ID: 36031472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor burden score-AFP-albumin-bilirubin grade score predicts the survival of patients with hepatocellular carcinoma after liver resection.
    Qiu ZC; Li C; Zhang Y; Xie F; Yu Y; Leng SS; Chen TH; Wen TF
    Langenbecks Arch Surg; 2023 Jun; 408(1):250. PubMed ID: 37382724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.